Pneumococcal 13-valent Conjugate Vaccine

BIOLOGICAL12 trials

Sponsors

Pfizer, Mayo Clinic, Jennifer Woyach, Sanofi Pasteur, a Sanofi Company, Emory University

Conditions

Aggressive Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaDiphtheriaHealthy VolunteersHealthy Volunteers (Meningococcal Infection)Indolent Non-Hodgkin LymphomaMeningococcal ImmunizationMonoclonal B-Cell Lymphocytosis

Phase 1

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

CompletedNCT03035331

Mayo ClinicAggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma +7

Start: 2017-08-15End: 2022-09-10Updated: 2025-05-16

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

RecruitingNCT03942328

Mayo ClinicStage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8 +3

Start: 2019-09-19End: 2028-02-29Target: 85Updated: 2026-02-24

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Active, not recruitingNCT06647407

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers, Meningococcal Immunization

Start: 2024-11-05End: 2027-05-17Target: 750Updated: 2026-01-20

Phase 2

Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis

TerminatedNCT02309515

Mayo ClinicMonoclonal B-Cell Lymphocytosis, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia +1

Start: 2015-06-11End: 2017-07-21Updated: 2021-01-19

Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Active, not recruitingNCT02518555

Jennifer WoyachChronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Start: 2016-01-12End: 2026-12-01Updated: 2026-01-07

Phase 3

NeisVac-C Single Prime Study in Infants

CompletedNCT01218451

PfizerNeisseria Meningitidis

Start: 2010-09-30End: 2012-06-30Updated: 2015-05-21

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

CompletedNCT03537508

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)

Start: 2018-04-25End: 2023-09-22Updated: 2024-10-15

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

CompletedNCT03630705

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)

Start: 2018-10-17End: 2022-02-18Updated: 2023-10-19

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

CompletedNCT03673462

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)

Start: 2018-09-17End: 2023-03-16Updated: 2023-12-14

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

CompletedNCT03691610

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)

Start: 2018-10-04End: 2023-10-20Updated: 2024-06-25

Phase 4

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

CompletedNCT04080531

Emory UniversityPlasma Cell Neoplasm

Start: 2019-10-18End: 2022-12-15Updated: 2025-02-28

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

CompletedNCT04535037

GlaxoSmithKlineDiphtheria

Start: 2021-05-26End: 2022-07-25Updated: 2024-08-27

Related Papers

Abstract 7935: Multimodal immunotherapy remodels the tumor microenvironment in hepatocellular carcinoma: Integrative spatial and transcriptomic profiling from a Phase II trial

Cancer Research2026-04-03

Abstract 3741: Radiation-dendritic cell combination therapy drives systemic cellular immune shifts in liver cancer

Cancer Research2026-04-03

Meningococcal quadrivalent ACYW-TT conjugated vaccine at 6–23 months: phase III study (US/Puerto Rico)

Pediatric Research2026-03-06

Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study

2026-01-01

Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study

2026-01-01

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico.

2025-12-03

Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study.

2025-12-01

221. Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) when Co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US and Puerto Rico

Open Forum Infectious Diseases2025-01-292 citations

P-632. Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers

Open Forum Infectious Diseases2025-01-291 citations

P-662. Phase III, modified double-blind, randomized, parallel group, active-controlled, multi-center study of Meningococcal quadrivalent ACWY conjugated vaccine in infants from 6 through 23 months of age in the United States

Open Forum Infectious Diseases2025-01-29

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico

OPAL (Open@LaTrobe) (La Trobe University)2025-01-01

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico

2025-01-01

Disparate kinetics in immune response of two different <i>Haemophilus influenzae</i> type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule

Human Vaccines & Immunotherapeutics2024-04-302 citations

689 Preliminary results of a pilot study of intratumoral injection of autologous dendritic cells after high-dose conformal external beam radiotherapy in unreseltable primary liver cancers

Regular and Young Investigator Award Abstracts2022-11-011 citations